Delineate vs Revvity

Side-by-side comparison of AI visibility scores, market position, and capabilities

Revvity leads in AI visibility (94 vs 26)
Delineate logo

Delineate

EmergingHealthcare Tech

General

US AI clinical trial design and systematic review automation extracting data from papers and figures at 15x industry speed for two top-10 pharma partners;

AI VisibilityBeta
Overall Score
D26
Category Rank
#460 of 1158
AI Consensus
57%
Trend
up
Per Platform
ChatGPT
27
Perplexity
37
Gemini
18

About

Delineate is a United States-based AI clinical trial design and biomedical data extraction company — providing pharmaceutical companies, academic research teams, and contract research organizations (CROs) with AI-powered systematic review automation that accelerates the data extraction and evidence synthesis workflows critical for designing better, faster clinical trials in the $10 billion clinical trial design and data services market. Partnered with two top-10 global pharmaceutical companies, Delineate has performed some of the largest systematic-review studies ever conducted in drug development, delivering 15x more processed studies than industry standard timelines and reducing certain study completion times from months to weeks through AI models that extract and analyze data from biopharma research papers, patents, and regulatory documents at scale.

Full profile
Revvity logo

Revvity

LeaderHealthcare Tech

Life Science Tools & Diagnostics

Revvity (RVTY) reported ~$2.9B revenue in FY2024. Life science tools and diagnostics company providing instruments, reagents, and software for genomics, newborn screening, and drug discovery. HQ: Waltham, MA.

AI VisibilityBeta
Overall Score
A94
Category Rank
#1 of 1
AI Consensus
72%
Trend
up
Per Platform
ChatGPT
92
Perplexity
99
Gemini
96

About

Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provider of solutions for reproductive health, genomics, and applied markets. The company operates in two segments: Life Sciences (analytical instruments, reagents, software for pharmaceutical and academic research) and Diagnostics (immunoassay and molecular diagnostic systems for clinical and screening applications). Revvity is the global leader in newborn screening, processing the tests that check newborns for metabolic and genetic disorders shortly after birth.

Full profile

AI Visibility Head-to-Head

26
Overall Score
94
#460
Category Rank
#1
57
AI Consensus
72
up
Trend
up
27
ChatGPT
92
37
Perplexity
99
18
Gemini
96
33
Claude
89
30
Grok
88

Key Details

Category
General
Life Science Tools & Diagnostics
Tier
Emerging
Leader
Entity Type
brand
company

Capabilities & Ecosystem

Capabilities

Only Revvity
Life Science Tools & Diagnostics

Integrations

Only Revvity
Revvity is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.